Ameriprise’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.16M | Buy |
232,886
+164,741
| +242% | +$1.53M | ﹤0.01% | 2900 |
|
|
2025
Q1 | $500K | Sell |
68,145
-21,627
| -24% | -$159K | ﹤0.01% | 3452 |
|
|
2024
Q4 | $767K | Buy |
89,772
+40,700
| +83% | +$348K | ﹤0.01% | 3332 |
|
|
2024
Q3 | $427K | Buy |
49,072
+12,529
| +34% | +$109K | ﹤0.01% | 3526 |
|
|
2024
Q2 | $250K | Buy |
36,543
+4,807
| +15% | +$32.9K | ﹤0.01% | 3639 |
|
|
2024
Q1 | $289K | Buy |
31,736
+2,736
| +9% | +$24.9K | ﹤0.01% | 3597 |
|
|
2023
Q4 | $129K | Sell |
29,000
-3,610
| -11% | -$16.1K | ﹤0.01% | 3787 |
|
|
2023
Q3 | $102K | Buy |
32,610
+2,605
| +9% | +$8.18K | ﹤0.01% | 3796 |
|
|
2023
Q2 | $155K | Sell |
30,005
-5,415
| -15% | -$27.9K | ﹤0.01% | 3762 |
|
|
2023
Q1 | $187K | Buy |
35,420
+5,020
| +17% | +$26.5K | ﹤0.01% | 3737 |
|
|
2022
Q4 | $85K | Sell |
30,400
-11,058
| -27% | -$30.9K | ﹤0.01% | 3823 |
|
|
2022
Q3 | $172K | Buy |
41,458
+600
| +1% | +$2.49K | ﹤0.01% | 3728 |
|
|
2022
Q2 | $164K | Buy |
40,858
+21,990
| +117% | +$88.3K | ﹤0.01% | 3708 |
|
|
2022
Q1 | $93K | Sell |
18,868
-3,350
| -15% | -$16.5K | ﹤0.01% | 3848 |
|
|
2021
Q4 | $155K | Buy |
+22,218
| New | +$155K | ﹤0.01% | 3823 |
|
|
2021
Q3 | – | Sell |
-11,413
| Closed | -$162K | – | 3916 |
|
|
2021
Q2 | $162K | Buy |
11,413
+123
| +1% | +$1.75K | ﹤0.01% | 3777 |
|
|
2021
Q1 | $186K | Sell |
11,290
-1,450
| -11% | -$23.9K | ﹤0.01% | 3710 |
|
|
2020
Q4 | $264K | Sell |
12,740
-1,830
| -13% | -$37.9K | ﹤0.01% | 3536 |
|
|
2020
Q3 | $111K | Buy |
14,570
+500
| +4% | +$3.81K | ﹤0.01% | 3625 |
|
|
2020
Q2 | $117K | Sell |
14,070
-5,518
| -28% | -$45.9K | ﹤0.01% | 3569 |
|
|
2020
Q1 | $97K | Buy |
19,588
+8,583
| +78% | +$42.5K | ﹤0.01% | 3538 |
|
|
2019
Q4 | $43K | Buy |
11,005
+5
| +0% | +$20 | ﹤0.01% | 3675 |
|
|
2019
Q3 | $33K | Buy |
+11,000
| New | +$33K | ﹤0.01% | 3668 |
|